Diamonds and Dogs
04/17/2012
Zynga Inc. (ZNGA)Zynga's logo is a dog and today that is just what Zynga is, down 5.80% at $10.31. The company is thought to be down today due to the fact that Zynga executives told Bloomberg that they were looking to make more acquisitions in the next few years. The latest acquisition of the company, OMGPop, cost Zynga $180 million. While such acquisitions will help Zynga to keep its games on the top of charts, it worries many investors. These investors are left questioning; will Zynga have to continue to buy its way to the top? Can the company continue to create popular new games, or has it lost its touch? Zynga is in a dog fight today, trying to keep its investors from bailing on them.
West Pharmaceutical Inc. (WST)
West Pharmaceutical isn't heading west today, just north, up 12.72% at $45.01. The company is up today based on the beating analysts' estimates. First quarter EPS estimates were at $0.65, compared to the actual EPS of $0.83. Furthermore the adjusted profit per share for 2012 rose from the range of $2.37-$2.55, to the range of $2.50-$2.67. The improved outlook for West Pharmaceutical forced the stock upward to an eight month high. With another solid day of trading the shares might be able reach the 52-week high. The market did extremely well today (Dow up 194 points, S&P up 21, and the Nasdaq up 54). With such a great day in the market many stocks were up, and West Pharmaceutical was able to post some of the largest gains.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.